Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$28.86 -0.79 (-2.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Gross Profit (2021 - 2026)

Updated

Lakefront Biotherapeutics' Gross Profit came in at $3.51 million for the quarter ended Jun 30, 2026, down 94.9% from $68.66 million a year earlier but up 78.1% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Gross Profit (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lakefront Biotherapeutics reported Gross Profit of -$33.46 billion; for the year ended Dec 31, 2025, it came in at -$32.34 billion.

  • Going back by year, Gross Profit was $260.61 million in the year ended Dec 31, 2024 (+9.3%), $238.54 million in the year ended Dec 31, 2023 (-1.2%), $241.54 million in the year ended Dec 31, 2022 (-12.3%) and $275.44 million in the year ended Dec 31, 2021.
  • The five-year range for quarterly Gross Profit is -$33.53 billion (the quarter ended Dec 31, 2025) to $565.73 million (the quarter ended Dec 31, 2023).
  • Year-over-year, Gross Profit increased in 1 of the last six quarters, with an average decline of 29.5%.
  • The fastest year-over-year change in Gross Profit over five years came in the quarter ended Sep 30, 2024 (growth of 165.2%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 96.9%).
  • Business Quant data shows LKFT's Gross Profit at $1.97 million (quarter ended Mar 31, 2026), -$33.53 billion (quarter ended Dec 31, 2025) and $70.43 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.51 Mn
Mar 31, 2026 1.97 Mn
Dec 31, 2025 -33.53 Bn
Sep 30, 2025 70.43 Mn
Jun 30, 2025 68.66 Mn
Mar 31, 2025 64.43 Mn
Dec 31, 2024 38.26 Mn
Sep 30, 2024 160.05 Mn
Jun 30, 2024 -26.48 Mn
Mar 31, 2024 65.06 Mn
Dec 31, 2023 565.73 Mn
Sep 30, 2023 60.36 Mn
Jun 30, 2023 60.76 Mn
Mar 31, 2023 59.04 Mn
Dec 31, 2022 -176.56 Mn
Sep 30, 2022 134.83 Mn
Jun 30, 2022 144.12 Mn
Mar 31, 2022 149.76 Mn
Dec 31, 2021 -96.60 Mn
Sep 30, 2021 374.07 Mn
API Access

Lakefront Biotherapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=LKFT&period=max&api_key=YOUR_API_KEY